Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs ARS Pharmaceuticals
Over the past year ARCT returned +12.8% and SPRY returned −62.4%; their daily moves had a correlation of 0.24.
ARCT +12.8% SPRY −62.4%Growth of $1, one year, split-adjusted
| Metric | ARCT | SPRY |
|---|---|---|
| Price | $12.15 | $3.66 |
| Market cap | $345.3M | $364.0M |
| Today | +0.66% | +0.27% |
| 1 month | −11.2% | −15.1% |
| 6 months | +41.0% | −55.7% |
| Year to date | +98.2% | −68.6% |
| 1 year | +23.0% | −61.0% |
| Revenue growth (YoY) | −89.5% | +114.2% |
| Gross margin | 100.0% | 61.8% |
| Net margin | −803.8% | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 3.1× |
| Net cash | $191.5M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 113.0% | 70.5% |
| Short % of float | 19.2% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).